Cognition and MRI Markers in MS Patients With Aubagio ® Treatment

Condition:   Multiple Sclerosis, Relapsing-Remitting Interventions:   Other: Clinical assessment;   Other: Ecological evaluation;   Other: Neuropsychological evaluation;   Other: Psychological evaluation;   Device: MRI Evaluation Sponsors:   University Hospital, Bordeaux;   Genzyme, a Sanofi Company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials